CHEMED CORP (CHE)
US16359R1032 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to CHE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 676.94. This target is 31.41% above the current price.
CHE was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CHE.
In the previous month the buy percentage consensus was at a similar level.
CHE was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-02-29 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-01-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-01 | RBC Capital | Maintains | Outperform |
| 2023-04-28 | Oppenheimer | Maintains | Outperform |
| 2023-02-27 | RBC Capital | Maintains | Outperform |
| 2022-11-03 | RBC Capital | Maintains | Outperform |
| 2022-08-01 | RBC Capital | Maintains | Outperform |
| 2022-04-28 | RBC Capital | Maintains | Outperform |
| 2022-03-04 | RBC Capital | Maintains | Outperform |
| 2021-07-29 | RBC Capital | Maintains | Outperform |
| 2021-02-25 | Oppenheimer | Maintains | Outperform |